DK1714647T3 - Anvendelse af agomelatin til fremstilling af et lægemiddel til behandling af bipolære sygdomme - Google Patents

Anvendelse af agomelatin til fremstilling af et lægemiddel til behandling af bipolære sygdomme

Info

Publication number: DK1714647T3
Authority: DK; Denmark
Prior art keywords: agomelatine; drug; manufacture; treatment; bipolar disorders
Prior art date: 2005-04-20

Application number

DK06290636.7T

Other languages

English (en)

Inventor

Bodinat Christian De

Elisabeth Mocaer

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-20

Filing date

2006-04-19

Publication date

2011-03-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35311309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1714647(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-04-19 Application filed by Servier Lab filed Critical Servier Lab

2011-03-07 Application granted granted Critical

2011-03-07 Publication of DK1714647T3 publication Critical patent/DK1714647T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

DK06290636.7T 2005-04-20 2006-04-19 Anvendelse af agomelatin til fremstilling af et lægemiddel til behandling af bipolære sygdomme DK1714647T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0503937A FR2884714B1 (fr)	2005-04-20	2005-04-20	Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires

Publications (1)

Publication Number	Publication Date
DK1714647T3 true DK1714647T3 (da)	2011-03-07

Family

ID=35311309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06290636.7T DK1714647T3 (da)	2005-04-20	2006-04-19	Anvendelse af agomelatin til fremstilling af et lægemiddel til behandling af bipolære sygdomme

Country Status (41)

Country	Link
US (1)	US7947743B2 (da)
EP (1)	EP1714647B1 (da)
JP (2)	JP4580364B2 (da)
KR (2)	KR100835451B1 (da)
CN (2)	CN102038669A (da)
AP (1)	AP2656A (da)
AR (1)	AR057277A1 (da)
AT (1)	ATE491443T1 (da)
AU (1)	AU2006201655B2 (da)
BR (1)	BRPI0601285A8 (da)
CA (1)	CA2544136C (da)
CR (1)	CR9426A (da)
CY (1)	CY1111257T1 (da)
DE (1)	DE602006018822D1 (da)
DK (1)	DK1714647T3 (da)
EA (1)	EA013462B1 (da)
ES (1)	ES2357901T3 (da)
FR (1)	FR2884714B1 (da)
GE (1)	GEP20094651B (da)
GT (1)	GT200600141A (da)
HR (1)	HRP20110083T1 (da)
IL (1)	IL186373A (da)
JO (1)	JO2666B1 (da)
MA (1)	MA28266A1 (da)
ME (1)	ME01951B (da)
MY (1)	MY143171A (da)
NO (1)	NO336010B1 (da)
NZ (1)	NZ546630A (da)
PE (1)	PE20061337A1 (da)
PL (1)	PL1714647T3 (da)
PT (1)	PT1714647E (da)
PY (1)	PY0610113A (da)
RS (1)	RS51659B (da)
SG (1)	SG126868A1 (da)
SI (1)	SI1714647T1 (da)
TN (1)	TNSN07364A1 (da)
TW (2)	TWI318115B (da)
UA (1)	UA83681C2 (da)
UY (1)	UY29470A1 (da)
WO (1)	WO2006111653A1 (da)
ZA (1)	ZA200603160B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2890563B1 (fr) *	2005-09-09	2007-10-19	Servier Lab	Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent
WO2008137461A1 (en) *	2007-05-01	2008-11-13	Concert Pharmaceuticals Inc.	Naphthyl(ethyl) acetamides
FR2978916B1 (fr) *	2011-08-10	2013-07-26	Servier Lab	Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2856934A1 (en) *	2013-10-04	2015-04-08	Les Laboratoires Servier	Biomarkers for the prediction of long term remission in depression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2658818B1 (fr) *	1990-02-27	1993-12-31	Adir Cie	Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5585118A (en) *	1995-06-02	1996-12-17	Brigham And Women's Hospital	Choline in the treatment of bipolar disorder
US7122576B2 (en) *	2001-02-27	2006-10-17	Plata-Salaman Carlos R	Carbamate compounds for use in preventing or treating bipolar disorder
FR2834890B1 (fr) *	2002-01-23	2004-02-27	Servier Lab	Composition pharmaceutique orodispersible d'agomelatine
AR047553A1 (es) *	2003-07-04	2006-01-25	Lundbeck & Co As H	La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
CA2551637A1 (en) *	2003-12-24	2005-07-14	Sepracor Inc.	Melatonin combination therapy for improving sleep quality

2005
- 2005-04-20 FR FR0503937A patent/FR2884714B1/fr not_active Expired - Fee Related
- 2005-06-01 US US11/142,612 patent/US7947743B2/en not_active Expired - Fee Related
2006
- 2006-04-04 JO JO200690A patent/JO2666B1/en active
- 2006-04-04 PE PE2006000362A patent/PE20061337A1/es not_active Application Discontinuation
- 2006-04-07 GT GT200600141A patent/GT200600141A/es unknown
- 2006-04-07 UY UY29470A patent/UY29470A1/es not_active Application Discontinuation
- 2006-04-11 UA UAA200604022A patent/UA83681C2/uk unknown
- 2006-04-11 SG SG200602393A patent/SG126868A1/en unknown
- 2006-04-17 MA MA28940A patent/MA28266A1/fr unknown
- 2006-04-18 NO NO20061705A patent/NO336010B1/no not_active IP Right Cessation
- 2006-04-19 MY MYPI20061783A patent/MY143171A/en unknown
- 2006-04-19 AT AT06290636T patent/ATE491443T1/de active
- 2006-04-19 ME MEP-2011-231A patent/ME01951B/me unknown
- 2006-04-19 ES ES06290636T patent/ES2357901T3/es not_active Expired - Lifetime
- 2006-04-19 TW TW095113952A patent/TWI318115B/zh not_active IP Right Cessation
- 2006-04-19 PL PL06290636T patent/PL1714647T3/pl unknown
- 2006-04-19 DE DE602006018822T patent/DE602006018822D1/de not_active Expired - Lifetime
- 2006-04-19 GE GEAP20069356A patent/GEP20094651B/en unknown
- 2006-04-19 DK DK06290636.7T patent/DK1714647T3/da active
- 2006-04-19 SI SI200630921T patent/SI1714647T1/sl unknown
- 2006-04-19 RS RS20110110A patent/RS51659B/sr unknown
- 2006-04-19 NZ NZ546630A patent/NZ546630A/en not_active IP Right Cessation
- 2006-04-19 EP EP06290636A patent/EP1714647B1/fr not_active Expired - Lifetime
- 2006-04-19 AR ARP060101537A patent/AR057277A1/es not_active Application Discontinuation
- 2006-04-19 AP AP2007004212A patent/AP2656A/xx active
- 2006-04-19 KR KR1020060035392A patent/KR100835451B1/ko not_active Expired - Fee Related
- 2006-04-19 TW TW098118938A patent/TW200940049A/zh unknown
- 2006-04-19 PT PT06290636T patent/PT1714647E/pt unknown
- 2006-04-19 EA EA200600600A patent/EA013462B1/ru not_active IP Right Cessation
- 2006-04-19 WO PCT/FR2006/000859 patent/WO2006111653A1/fr not_active Ceased
- 2006-04-20 CA CA2544136A patent/CA2544136C/fr not_active Expired - Fee Related
- 2006-04-20 CN CN2010105781057A patent/CN102038669A/zh active Pending
- 2006-04-20 BR BRPI0601285A patent/BRPI0601285A8/pt not_active IP Right Cessation
- 2006-04-20 JP JP2006116294A patent/JP4580364B2/ja not_active Expired - Fee Related
- 2006-04-20 CN CN2006100764985A patent/CN1853619B/zh not_active Expired - Fee Related
- 2006-04-20 AU AU2006201655A patent/AU2006201655B2/en not_active Ceased
- 2006-04-20 PY PY200600610113A patent/PY0610113A/es unknown
- 2006-04-20 ZA ZA200603160A patent/ZA200603160B/en unknown
2007
- 2007-09-26 TN TNP2007000364A patent/TNSN07364A1/en unknown
- 2007-10-07 IL IL186373A patent/IL186373A/en not_active IP Right Cessation
- 2007-10-08 CR CR9426A patent/CR9426A/es not_active Application Discontinuation
2008
- 2008-02-29 KR KR1020080018845A patent/KR20080028389A/ko not_active Ceased
2010
- 2010-08-06 JP JP2010177003A patent/JP5341037B2/ja not_active Expired - Fee Related
2011
- 2011-02-02 HR HR20110083T patent/HRP20110083T1/hr unknown
- 2011-02-23 CY CY20111100222T patent/CY1111257T1/el unknown

Also Published As

Publication number	Publication date
TWI318115B (en)	2009-12-11
CA2544136A1 (fr)	2006-10-20
CY1111257T1 (el)	2015-08-05
AR057277A1 (es)	2007-11-28
EP1714647B1 (fr)	2010-12-15
HK1093906A1 (en)	2007-03-16
GEP20094651B (en)	2009-03-25
FR2884714A1 (fr)	2006-10-27
AP2656A (en)	2013-05-07
BRPI0601285A (pt)	2006-12-19
DE602006018822D1 (de)	2011-01-27
TW200716083A (en)	2007-05-01
US7947743B2 (en)	2011-05-24
CN1853619A (zh)	2006-11-01
NZ546630A (en)	2007-09-28
MA28266A1 (fr)	2006-11-01
HRP20110083T1 (hr)	2011-03-31
CN1853619B (zh)	2011-02-02
BRPI0601285A8 (pt)	2021-03-30
NO336010B1 (no)	2015-04-20
CN102038669A (zh)	2011-05-04
TNSN07364A1 (en)	2008-12-31
TW200940049A (en)	2009-10-01
AP2007004212A0 (en)	2007-10-31
JP2010280699A (ja)	2010-12-16
MY143171A (en)	2011-03-31
PL1714647T3 (pl)	2011-05-31
US20060240127A1 (en)	2006-10-26
ATE491443T1 (de)	2011-01-15
PT1714647E (pt)	2011-01-14
EP1714647A1 (fr)	2006-10-25
ME01951B (me)	2011-10-31
JP5341037B2 (ja)	2013-11-13
WO2006111653A1 (fr)	2006-10-26
GT200600141A (es)	2006-11-22
ES2357901T3 (es)	2011-05-03
FR2884714B1 (fr)	2011-05-06
EA200600600A1 (ru)	2006-10-27
ZA200603160B (en)	2007-06-27
AU2006201655A1 (en)	2006-11-09
CA2544136C (fr)	2012-02-21
IL186373A (en)	2012-06-28
JO2666B1 (en)	2012-06-17
UY29470A1 (es)	2006-05-31
UA83681C2 (uk)	2008-08-11
JP4580364B2 (ja)	2010-11-10
JP2006316056A (ja)	2006-11-24
RS51659B (sr)	2011-10-31
KR20080028389A (ko)	2008-03-31
KR100835451B1 (ko)	2008-06-09
SI1714647T1 (sl)	2011-03-31
PY0610113A (es)	2011-01-03
IL186373A0 (en)	2008-08-07
KR20060110803A (ko)	2006-10-25
AU2006201655B2 (en)	2009-04-23
PE20061337A1 (es)	2007-01-27
EA013462B1 (ru)	2010-04-30
CR9426A (es)	2008-02-21
SG126868A1 (en)	2006-11-29
NO20061705L (no)	2006-10-23

Publication	Publication Date	Title
DK2019683T4 (da)	2022-08-29	Indgivelse af vækstfaktorer til behandling af CNS-lidelser
DK1928438T3 (da)	2013-04-22	Anvendelse af ibudilast til behandling af stofafhængighed
DK2504005T3 (da)	2014-01-13	Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK1869025T3 (da)	2011-04-04	Piperazin-substituerede benzothiophener til behandling af mentale lidelser
DK2187878T3 (da)	2011-09-19	Anvendelse af en betablokker til fremstilling af et medikament til behandling af hæmangiomer
DK1812110T3 (da)	2013-09-16	Apparat til behandling af dermatologiske lidelser
BRPI0714539A2 (pt)	2014-02-25	"formas farmacêuticas"
DK2474321T3 (da)	2019-06-03	Sammensætninger til behandling af collagenmedierede sygdomme
DK2056842T3 (da)	2013-01-14	Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK1708992T3 (da)	2007-11-05	Sulfonamidderivater til behandling af sygdomme
DK1937633T3 (da)	2010-10-11	Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
DK1890684T3 (da)	2013-10-14	Behandling af søvn/vågenhedsforstyrrelser
DK1817282T3 (da)	2011-10-10	Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK1685834T3 (da)	2009-07-20	Anvendelse af pinolensyre til behandling af obesitet
DK1868600T3 (da)	2012-08-27	Spirocyklisk cyclohexanderivat til behandling af stofafhængighed
DK2422786T3 (da)	2014-11-17	Nye lægemiddelkombinationer til behandling af luftvejssygdomme
DK1765355T3 (da)	2013-04-08	Benzoxazin til behandling af luftvejslidelser
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
DK2117565T3 (da)	2012-11-19	Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK1940409T3 (da)	2010-11-29	Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
DK1962869T3 (da)	2013-06-24	Behandling af luftvejssygdomme
DK1841433T3 (da)	2012-01-16	Præparat til behandling af lidelser i centralnervesystemet
DE502005002324D1 (de)	2008-01-31	Reaktor zur behandlung hochviskoser kunststoffschmelzen
DK3332789T3 (da)	2022-07-11	Cladribinkur til behandling af multipel sklerose
DK1907374T3 (da)	2012-10-15	Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater